The webinar will be delivered by Dr. Hedy Kindler, Associate Professor of Medicine, Medical Director, Gastrointestinal Oncology, Director, Mesothelioma Program at the University of Chicago.

Upon completion of this educational activity, participants should be able to:

1. Describe the available front-line therapeutic options for patients with metastatic pancreatic cancer

2. Compare the relative effectiveness and potential side effect profiles of different chemotherapeutic regimens for advanced pancreatic cancer

3. To outline future opportunities in the therapy of pancreatic cancer